Edoxaban Monotherapy in Nonvalvular Atrial Fibrillation Patients with Coronary Artery Disease by Daisuke Fukamachi, Yasuo Okumura, Naoya Matsumoto, Eizo Tachibana, Koji Oiwa, Makoto Ichikawa, Hironori Haruta, Kazumiki Nomoto, Ken Arima, Atsushi Hirayama

“…Current guidelines recommend an oral anticoagulant (OAC) monotherapy in patients with nonvalvular atrial fibrillation (NVAF) and stable coronary artery disease (CAD) 1 year postpercutaneous coronary intervention (PCI). …”
Get full text

Anaesthetic Management of Parturient with Acute Atrial Fibrillation for Emergency Caesarean Section by Madhu Gupta, Shalini Subramanian, Preeti Adlakha

“…She had acute onset atrial fibrillation. She was given a combined spinal epidural (CSE) anaesthesia and her arrhythmia was successfully managed after delivery of the baby with intravenous calcium channel blocker. …”
Get full text

Tailoring the Ablative Strategy for Atrial Fibrillation: A State-of-the-Art Review by Zefferino Palamà, Martina Nesti, Antonio Gianluca Robles, Antonio Scarà, Silvio Romano, Elena Cavarretta, Maria Penco, Pietro Delise, Mariano Rillo, Leonardo Calò, Luigi Sciarra

“…In spite of technological progress and the improving skills of operators, atrial fibrillation (AF) ablation results appear to date to be at a plateau. …”
Get full text

Non-Pharmacological Therapy for Atrial Fibrillation: Managing the Left Atrial Appendage by Sushil Allen Luis, Damian Roper, Alexander Incani, Karl Poon, Haris Haqqani, Darren L. Walters

“…The prevalence of atrial fibrillation (AF) is increasing in parallel with an ageing population leading to increased morbidity and mortality. …”
Get full text

“Pharmacological” analysis of atrial fibrillation maintenance mechanism: reentry, wavelets, or focal? by Alexander Burashnikov

Subjects: “…atrial fibrillation…”
Get full text

Patients’ Experiences of Living with Atrial Fibrillation: A Mixed Methods Study by Marie Stridsman, Anna Strömberg, Jeroen Hendriks, Ulla Walfridsson

“…Awareness of epidemiological and clinical consequences of atrial fibrillation (AF) has increased, as have disease-related costs. …”
Get full text

“Wait and See” Approach to the Emergency Department Cardioversion of Acute Atrial Fibrillation by Brian Doyle, Mark Reeves

“…Objective. Acute atrial fibrillation often spontaneously resolves. This study aimed to investigate the outcomes and satisfaction of an evidence-based ED protocol employing a “wait and see” approach. …”
Get full text

Molecular Signatures of Human Chronic Atrial Fibrillation in Primary Mitral Regurgitation by Günseli Çubukçuoğlu Deniz, Serkan Durdu, Yeşim Doğan, Esra Erdemli, Hilal Özdağ, Ahmet Ruchan Akar

“…Transcriptomics of atrial fibrillation (AFib) in the setting of chronic primary mitral regurgitation (MR) remains to be characterized. …”
Get full text

Atrial Fibrillation Caused by Intractable Hiccups: A Unique Cause and Cure by Joshua H. Arnold, Neil Brandon

“…We present the case of a 61-year-old male who developed persistent hiccups concurrently with the onset of atrial fibrillation (AF). The hiccups were refractory to traditional treatment but resolved immediately upon electrical cardioversion (ECV) to normal sinus rhythm (NSR). …”
Get full text

AI prediction model for endovascular treatment of vertebrobasilar occlusion with atrial fibrillation by Zhi-Xin Huang, Andrea M. Alexandre, Alessandro Pedicelli, Xuying He, Quanlong Hong, Yongkun Li, Ping Chen, Qiankun Cai, Aldobrando Broccolini, Luca Scarcia, Serena Abruzzese, Carlo Cirelli, Mauro Bergui, Andrea Romi, Erwah Kalsoum, Giulia Frauenfelder, Grzegorz Meder, Simona Scalise, Maria Porzia Ganimede, Luigi Bellini, Bruno Del Sette, Francesco Arba, Susanna Sammali, Andrea Salcuni, Sergio Lucio Vinci, Giacomo Cester, Luisa Roveri, Xianjun Huang, Wen Sun

“…Abstract Endovascular treatment (EVT) for vertebrobasilar artery occlusion (VBAO) with atrial fibrillation presents complex clinical challenges. …”
Get full text

Telomere Length Is Associated With Adverse Atrial Remodeling in Patients With Atrial Fibrillation by Kabita Pradhan, Balram Neupane, Paul Niehues, Martin Kirschner, Fabian Beier, Chao‐Chung Kuo, Erika Anneliese Hilbold, Christian Bär, Oana‐Maria Thoma, Maximilian Waldner, Margherita Vieri, Tim H. Brümmendorf, Vithurithra Tharmapalan, Wolfgang Wagner, Michael Kleines, Mahdi Emrani, Matthias Daniel Zink, Andreas Napp, Nikolaus Marx, Michael Gramlich

Subjects: Get full text

Meta-Analysis of Atrial Fibrillation Ablation in Patients with Systolic Heart Failure by Mohammed Ruzieh, Andrew J. Foy, Nader M. Aboujamous, Morgan K. Moroi, Gerald V. Naccarelli, Mehrdad Ghahramani, Shaffi Kanjwal, Joseph E. Marine, Khalil Kanjwal

“…Atrial fibrillation (AF) and heart failure (HF) are two common conditions that often coexist and predispose each to one another. …”
Get full text

Cost-effectiveness of Apixaban for Stroke Prevention in Patients with Atrial Fibrillation in Algeria by Yazid Aoudia, Thitima Kongnakorn, Evie Merinopoulou, Mohamed Said Bettayeb, Sid Ahmed Kherraf

“…**Background:** Atrial fibrillation (AF) is a chronic sustained heart rhythm disorder associated with an increased risk of stroke. …”
Get full text

Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF) by Raffaele De Caterina, Kurt Huber, Richard Schilling, Miklos Rohla, Thomas W Weiss, Ladislav Pecen, Giuseppe Patti, Jolanta M Siller-Matula, Renate B Schnabel, Dipak Kotecha, Markus Lucerna, Paulus Kirchhof

“…Objectives We identified factors associated with thromboembolic and bleeding events in two contemporary cohorts of anticoagulated patients with atrial fibrillation (AF), treated with either vitamin K antagonists (VKA) or non-VKA oral anticoagulants (NOACs).Design Prospective, multicentre observational study.Setting 461 centres in seven European countries.Participants 5310 patients receiving a VKA (PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF), derivation cohort) and 3156 patients receiving a NOAC (PREFER in AF Prolongation, validation cohort) for stroke prevention in AF.Outcome measures Risk factors for thromboembolic events (ischaemic stroke, systemic embolism) and major bleeding (gastrointestinal bleeding, intracerebral haemorrhage and other life-threatening bleeding).Results The mean age of patients enrolled in the PREFER in AF registry was 72±10 years, 40% were female and the mean CHA2DS2-VASc Score was 3.5±1.7. …”
Get full text

Attributable Costs of Postoperative Atrial Fibrillation among Patients Undergoing Cardiac Surgery by Pattamawan Kosuma, Sitichok Wachirasrisirikul, Arom Jedsadayanmata

“…Background. Postoperative atrial fibrillation (POAF) is the most common complication among patients undergoing cardiac surgery. …”
Get full text

Atrial fibrillation in acute coronary syndrome: clinical and anamnestic features and effects on the course by V.І. Tseluyko, F.B. Salem, N.A. Lopina, I.V. Kuznetsov

Subjects: Get full text

A knowledge embedded multimodal pseudo-siamese model for atrial fibrillation detection by Chenglin Lin, Huimin Lu, Pengcheng Sang, Chenyu Pan

“…Abstract Atrial fibrillation (AF) is a common arrhythmia disease with a higher incidence rate. …”
Get full text

Effects of key parameters on pulsed field ablation of atrial fibrillation: potato experiments by Yunhao Li, Yunhao Li, Fengqi Xuan, Daoyang Zhang, Daoyang Zhang, Mingyu Sun, Mingyu Sun, Ping Zhang, Qi Zhang, Jie Zhang, Yaling Han, Yaling Han, Zulu Wang, Ming Liang, Ming Liang

Get full text

Relation of Biomarkers of Inflammation and Oxidative Stress with Hypertension Occurrence in Lone Atrial Fibrillation by Marija M. Polovina, Miodrag C. Ostojic, Tatjana S. Potpara

“…We compared plasma levels of biomarkers of inflammation (CRP) and oxidation (oxLDL), determined at study inclusion in lone atrial fibrillation (LAF) patients (48.6±11.5 years; 74.0% men) and sinus rhythm controls (49.7±9.3 years; 72.7% men, P>0.05), and investigated the association of baseline CRP and oxLDL levels with the risk for vascular disease (VD) development (hypertension, cerebrovascular disease, coronary/peripheral artery disease, and pulmonary embolism) during prospective follow-up. …”
Get full text

Influence of catheter ablation for atrial fibrillation on atrial and ventricular functional mitral regurgitation by Masaharu Masuda, Kimiko Sekiya, Mitsutoshi Asai, Osamu Iida, Shin Okamoto, Takayuki Ishihara, Kiyonori Nanto, Takashi Kanda, Takuya Tsujimura, Yasuhiro Matsuda, Yosuke Hata, Hiroyuki Uematsu, Taku Toyoshima, Naoko Higashino, Toshiaki Mano

Subjects: Get full text